Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India

PARIS and NEW DELHI, India, Sept. 20 /PRNewswire/ -- Cellectis
bioresearch, the specialist in genome customization and subsidiary
of Cellectis (Alternext: ALCLS), and Helix BioService &
Consultants Pvt Ltd (Helix Biocon), today announced that they will
join forces for the promotion of Cellectis bioresearch's
meganuclease-based products and services in India. Helix Biocon is
a young company comprised of professionals with proven expertise in
the field of Life sciences, pharmaceuticals and drug discovery
research. The companies will pool their expertise to ensure maximum
availability for the innovative cellular Genome Positioning System
(cGPS®) lines of products and to promote cell line engineering
service for bioproduction.

"Cellectis bioresearch aims to make its products the gold
standard in genome customization for the life science community
throughout the world," said Luc Selig, VP Sales & Marketing
at Cellectis bioresearch. "India, as a major player in
bioproduction, is a key market for our cell line engineering
services. This new collaboration with Helix Biocon will bring our
full line of products and services to the growing Indian science
community."

Cellectis bioresearch's portfolio today offers over 100 product
references, addressing the major needs for genome customization of
the life science community.

"We believe Cellectis bioresearch has exciting product lines
for top level researchers in pharmaceutical, drug discovery and
academia and is poised to redefine genome engineering," said R.
Agarwal, Business Director of Helix Biocon. "By providing the
cGPS® lines of products coupled with Cellectis'
technology transfer and partnership services, Helix Biocon shall be
able to offer game changing tools to our Indian customers to assist
them in the pursuit of tomorrow's most important scientific
discoveries."